Join a conversation on ways to guide the development of the evolving field of comparative effectiveness research (CER), evaluate its results, and communicate the findings at "Putting Patients First: Paving a Path to Useful CER," a symposium sponsored by both the National Health Council (NHC) and the National Pharmaceutical Council (NPC) and co-sponsored by PCORI and the Pharmaceutical Research and Manufacturers of America. The event will be held at the W Hotel in Washington, D.C. on Monday, Sept. 30. Click here to register.
As the research funded by PCORI moves closer to producing tangible results, the patient community must engage in discussions to answer two essential questions:
We hope you will consider reserving a spot at the event. Stakeholders in CER – including patient groups, policymakers, investigators, and sponsors of research – will engage in a dialogue on the development, evaluation and communication of research results. The symposium will address the development of a CER usability criteria framework proposed by the NHC and based on research by Avalere Health. Click here for additional information, and to register for the event.
- How should these results be used to benefit the populations and individuals who, historically, have been disenfranchised by the research?
- How can we assure that patient-centered outcomes research/CER improves clinical care and provides an improved pathway to more inclusive and diverse health care research and innovation?
We hope you will consider reserving a spot at the event. Stakeholders in CER – including patient groups, policymakers, investigators, and sponsors of research – will engage in a dialogue on the development, evaluation and communication of research results. The symposium will address the development of a CER usability criteria framework proposed by the NHC and based on research by Avalere Health. Click here for additional information, and to register for the event.
